4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease

Journal of Neurochemistry

Volumn 68, Issue 5, 1997, Pages 2092-2097

  Sayre, Lawrence M ^a   Zelasko, Dawn A ^a   Harris, Peggy L R ^a   Perry, George ^a   Salomon, Robert G ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Hydroxynonenal; Neurofibrillary tangles; Oxidative stress; protein

Indexed keywords

4 HYDROXYNONENAL;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; SENILE PLAQUE;

ORYCTOLAGUS CUNICULUS;

EID: 0030989545     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68052092.x     Document Type: Article

References (23)

1. Basu-Modak S., Luscher P., and Tyrrell R. M. (1996) Lipid metabolite involvement in the activation of the human heme oxygenase-1 gene. Free Radic. Biol. Med. 20, 887-897.
2. Bowling A. C. and Beal M. F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171.
3. Esterbauer H., Schaur R. J., and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
4. Good P. F., Werner P., Hsu A., Olanow C. W., and Perl D. P. (1996) Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
5. Khachaturian Z. S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol. 42, 1097-1105.
6. Ledesma M. D., Bonay P., Colaco C., and Avila J. (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269, 21614-21619.
7. Montine T. J., Amarnath V., Martin M. E., Strittmatter W. J., and Graham D. G. (1996a) E-4-Hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148, 89-93.
8. Montine T. J., Huang D. Y., Valentine W. M., Amarnath V., Saunders A., Weisgraber K. H., Graham D. G., and Strittmatter W. J. (1996b) Crosslinking of apolipoprotein E by products of lipid peroxidation. J. Neuropathol. Exp. Neurol. 55, 202-210.
9. Nadkarni D. V. and Sayre L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284-291.
10. Perry G., Kawai M., Tabaton M., Onorato M., Mulvihill P., Richey P., Morandi A., Connolly J. A., and Gambetti P. (1991) Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. J. Neurosci. 11, 1748-1755.
11. Praprotnik D., Smith M. A., Richey P. L., Vinters H. V., and Perry G. (1996) Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress. Acta Neuropathol. (Berl.) 91, 1-5.
12. Sayre L. M., Arora P. K., Iyer R. S., and Salomon R. G. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22.
13. Sayre L. M., Sha W., Xu G., Kaur K., Nadkarni D., Subbanagounder G., and Salomon R. G. (1996) Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 9, 1194-1201.
14. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M., and Perry G. (1994a) Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91, 5710-5714.
15. Smith M. A., Kutty R. K., Richey P. L., Yan S.-D., Stern D., Chader G. J., Wiggert B., Petersen R. B., and Perry G. (1994b) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145, 42-47.
16. Smith M. A., Sayre L. M., Monnier V. M., and Perry G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
17. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F., and Kowall N. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
18. Smith M. A., Harris P. L. R., Sayre L. M., Beckman J. S., and Perry G. (1997) Widespread peroxynitrite mediated damage in Alzheimer disease. J. Neurosci. (in press).
19. Strittmatter W. J. and Roses A. D. (1995) Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 4725-4727.
20. Uchida K., Itakura K., Kawakishi S., Hiai H., Toyokuni S., and Stadtman E. R. (1995) Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 324, 241-248.
21. Vitek M. P., Bhattcharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., and Cerami A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 4766-4770.
22. Yan S.-D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y.-S., Scott C. W., Caputo C., Frappier T., Smith M. A., Perry G., Yen S.-H., and Stern D. (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91, 7787-7791.
23. Yan S. D., Yan S. F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M. A., Perry G., Godman G. C., Nawroth P., Zweier J. L., and Stern D. (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat. Med. 1, 693-699.